Alfresa HoldingsALFRY 75 Buyback Yield % is 0.05 as of Jul. 07, 2026, which is 98% below its 10-year median of 3.03. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.25 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 39 Medical Distribution companies, Alfresa Holdings ranks worse than 51.28% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Alfresa Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALFRY vs MCK, CAH, COR: Buyback Yield % Comparison
For the Medical Distribution subindustry, Alfresa Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (ALFRY) has a Buyback Yield % of 0.05 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Alfresa Holdings and its competitors. This is 98% below median its historical median of 3.03. Over the past decade, Alfresa Holdings' Buyback Yield % has ranged from 0.04 to 8.64. According to the industry distribution chart, Alfresa Holdings ranks #20 out of 39 companies in the Medical Distribution industry, placing it in the top 51.3%.
Is Alfresa Holdings' Buyback Yield % too high?
Alfresa Holdings' current Buyback Yield % of 0.05 is 98% below median its 10-year median of 3.03. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 8.64. The Medical Distribution industry median Buyback Yield % is 0.05. Alfresa Holdings' value of 0.05 is 0% at this industry median. Based on the distribution chart, Alfresa Holdings ranks #20 out of 39 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Buyback Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #20 out of 39 companies for Buyback Yield %. This places Alfresa Holdings in the lower half of its industry. The industry median Buyback Yield % is 0.05. Alfresa Holdings' value of 0.05 is 0% at this benchmark. Historically, Alfresa Holdings' own Buyback Yield % has ranged from 0.04 to 8.64 over the past decade. While the company's 10-year median is 3.03 vs. the industry median of 0.05, Alfresa Holdings has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.05, based on 39 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Buyback Yield % of 0.05 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Buyback Yield % is 0.05, which is 98% below median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.25, compared to a current price of $13.80 — trading 15.1% below its estimated fair value. The current Buyback Yield % is 0.05, which is 98% below median its 10-year median of 3.03 and 0% at the Medical Distribution industry median of 0.05. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Buyback Yield % is 0.05 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.80 is trading 15.1% below its estimated GF Value™ of $16.25.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
Buyback Yield %: 0.05 (98% below median its 10-year median of 3.03)
GF Value™: $16.25 vs. price of $13.80 (15.1% below fair value)
Industry Position: 0% at the Medical Distribution median (#20 of 39)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
